Immunotherapy for hepatocellular carcinoma: The challenge of biomarker studies

J Chin Med Assoc. 2021 Feb 1;84(2):121-122. doi: 10.1097/JCMA.0000000000000458.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Biomarkers
  • Carcinoma, Hepatocellular* / therapy
  • Humans
  • Immunologic Factors
  • Immunotherapy
  • Liver Neoplasms* / therapy

Substances

  • Biomarkers
  • Immunologic Factors